Alyeska Investment Group’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-145,466
Closed -$25.6M – 714
2025
Q2
$25.6M Buy
+145,466
New +$21.9M 0.09% 249
2022
Q3
– Sell
-348,836
Closed -$18.3M – 490
2022
Q2
$18.3M Buy
348,836
+85,986
+33% +$5.98M 0.21% 154
2022
Q1
$22.6M Buy
+262,850
New +$21.6M 0.25% 134
2015
Q3
– Sell
-13,249
Closed -$767K – 527
2015
Q2
$767K Buy
+13,249
New +$677K 0.01% 422

Other funds holding THC

Alyeska Investment Group's THC Position: Q3 2025 in Review

Alyeska Investment Group sold out of Tenet Healthcare (THC) in Q3 2025, closing a stake of 145,466 shares — an estimated $25.6M sold.

Alyeska Investment Group first reported a position in THC in Q2 2015 and held it in 4 quarters. The position peaked at $25.6M in Q2 2025. 680 funds tracked by Wall St. Rank hold THC as of Q3 2025.

  • Alyeska Investment Group reported no remaining Tenet Healthcare position as of Q3 2025 after selling out during the quarter.
  • Alyeska Investment Group sold 145,466 Tenet Healthcare shares in Q3 2025, an estimated $25.6M.
  • Alyeska Investment Group first reported a position in Tenet Healthcare in Q2 2015 and held it in 4 quarters.
  • Alyeska Investment Group's Tenet Healthcare position peaked at $25.6M in Q2 2025.
  • 680 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2025.

Based on Alyeska Investment Group's 13F filing for Q3 2025, filed 17 Nov 2025.